IL283990A - Modified oxopyridine derivatives - Google Patents

Modified oxopyridine derivatives

Info

Publication number
IL283990A
IL283990A IL283990A IL28399021A IL283990A IL 283990 A IL283990 A IL 283990A IL 283990 A IL283990 A IL 283990A IL 28399021 A IL28399021 A IL 28399021A IL 283990 A IL283990 A IL 283990A
Authority
IL
Israel
Prior art keywords
oxopyridine derivatives
substituted oxopyridine
substituted
derivatives
oxopyridine
Prior art date
Application number
IL283990A
Other languages
English (en)
Hebrew (he)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL283990A publication Critical patent/IL283990A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL283990A 2018-12-21 2021-06-14 Modified oxopyridine derivatives IL283990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2018122825 2018-12-21
PCT/EP2019/085983 WO2020127504A1 (fr) 2018-12-21 2019-12-18 Dérivés d'oxopyridine substitués

Publications (1)

Publication Number Publication Date
IL283990A true IL283990A (en) 2021-07-29

Family

ID=69143542

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283990A IL283990A (en) 2018-12-21 2021-06-14 Modified oxopyridine derivatives

Country Status (22)

Country Link
EP (1) EP3898633A1 (fr)
JP (1) JP2022514303A (fr)
KR (1) KR20210106504A (fr)
CN (1) CN113474348A (fr)
AR (1) AR117435A1 (fr)
AU (1) AU2019407909B2 (fr)
BR (1) BR112021009435A2 (fr)
CA (1) CA3124220A1 (fr)
CL (1) CL2021001613A1 (fr)
CO (1) CO2021007908A2 (fr)
CR (1) CR20210342A (fr)
DO (1) DOP2021000128A (fr)
EA (1) EA202191764A1 (fr)
EC (1) ECSP21043895A (fr)
IL (1) IL283990A (fr)
JO (1) JOP20210161A1 (fr)
MA (1) MA54521A (fr)
MX (1) MX2021007508A (fr)
PE (1) PE20211790A1 (fr)
SG (1) SG11202104384PA (fr)
TW (1) TW202039510A (fr)
WO (1) WO2020127504A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020018562A2 (pt) * 2018-03-15 2020-12-29 Bayer Aktiengesellschaft Processo preparativo
CN114105881B (zh) 2020-08-31 2024-01-26 沈阳海诺威医药科技有限公司 血小板聚集抑制剂及其制备方法和用途
MX2023010629A (es) 2021-03-09 2023-09-19 Bayer Ag Formas de dosificacion farmaceuticas que comprenden (4s)-24-cloro-4-etil-7?-fluoro-35-metoxi-3?,5-dioxo-14-(trifluoro metil)-3?h-6-aza-3(4,1)-piridina-1(1)-[1,2,3]triazola-2(1,2),7(1) -dibencenaheptafano-74-carboxamida.
JP2024508971A (ja) 2021-03-09 2024-02-28 バイエル・アクチエンゲゼルシヤフト (4s)-24-クロロ-4-エチル-73-フルオロ-35-メトキシ-32,5-ジオキソ-14-(トリフルオロメチル)-32h-6-アザ-3(4,1)-ピリジナ-1(1)-[1,2,3]トリアゾラ-2(1,2),7(1)-5 ジベンゼナヘプタファン-74-カルボキサミドの結晶形態
WO2022189280A1 (fr) 2021-03-09 2022-09-15 Bayer Aktiengesellschaft Solvates de (4s)-24-chloro-4-éthyl-73-fluoro-35-méthoxy-32,5-dioxo-14-(trifluoro-méthyl)-32 h-6- aza-3(4,1)-pyridina-1(1)-[1,2,3]triazola-2(1,2),7(1)-dibenzenaheptaphane-74-carboxamide
CN114560754A (zh) * 2022-02-25 2022-05-31 滁州学院 一种烷基醇的制备方法
CN116874469B (zh) * 2023-09-06 2023-11-10 成都施贝康生物医药科技有限公司 一种氧代吡啶类化合物、中间体及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
DE102006032824A1 (de) * 2006-07-14 2008-01-17 Bayer Healthcare Ag Substituierte Indazole
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
US9809545B2 (en) 2013-03-27 2017-11-07 Merck Sharp & Dohme Corp. Factor XIa inhibitors
TWI633089B (zh) 2013-03-28 2018-08-21 拜耳製藥股份有限公司 經取代的酮基吡啶衍生物
JP6410819B2 (ja) 2013-07-23 2018-10-24 バイエル ファーマ アクチエンゲゼルシャフト 置換オキソピリジン誘導体および第XIa因子/血漿としてのその使用
WO2015063093A1 (fr) 2013-10-30 2015-05-07 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine substituée
EP3197880B1 (fr) 2014-09-24 2018-10-24 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine substitués à effet anti-inflammatoire et anti-thrombotique
US10138236B2 (en) * 2014-09-24 2018-11-27 Bayer Pharma Aktiengesellschaft Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
EP3197873B1 (fr) 2014-09-24 2018-10-24 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine substitués
EP3197889B1 (fr) 2014-09-24 2018-08-01 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine substitués
US10077265B2 (en) * 2014-09-24 2018-09-18 Bayer Pharma Aktiengesellschaft Substituted oxopyridine derivatives
EP3197872B1 (fr) 2014-09-24 2019-01-30 Bayer Pharma Aktiengesellschaft (2h)-2-oxopyridines en tant qu'inhibiteurs du facteur xia pour le traitement de maladies thrombotiques
EP3271332A1 (fr) * 2015-03-19 2018-01-24 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine comme inhibiteurs du facteur xia pour le traitement de la thrombose
JO3703B1 (ar) 2015-07-09 2021-01-31 Bayer Pharma AG مشتقات أوكسوبيريدين مستبدلة
EP3344618A1 (fr) 2015-09-04 2018-07-11 Bayer Pharma Aktiengesellschaft Dérivés d'oxopyridine substitués

Also Published As

Publication number Publication date
EP3898633A1 (fr) 2021-10-27
DOP2021000128A (es) 2021-09-30
TW202039510A (zh) 2020-11-01
CN113474348A (zh) 2021-10-01
BR112021009435A2 (pt) 2021-08-17
WO2020127504A1 (fr) 2020-06-25
SG11202104384PA (en) 2021-05-28
AU2019407909B2 (en) 2023-05-25
CO2021007908A2 (es) 2021-07-19
KR20210106504A (ko) 2021-08-30
CR20210342A (es) 2021-08-09
ECSP21043895A (es) 2021-07-30
JP2022514303A (ja) 2022-02-10
PE20211790A1 (es) 2021-09-09
EA202191764A1 (ru) 2021-10-22
JOP20210161A1 (ar) 2023-01-30
CL2021001613A1 (es) 2021-12-03
CA3124220A1 (fr) 2020-06-25
AR117435A1 (es) 2021-08-04
MX2021007508A (es) 2021-08-05
MA54521A (fr) 2022-03-30
AU2019407909A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
HUE060181T2 (hu) Szubsztituált alkoxipiridinil-indolszulfonamidok
IL283197A (en) Biocidal 2-acylamino-thiazole-4-carboxamide derivatives
IL271607B1 (en) New azaquinoline histories
CA185382S (en) Casque
ZA202204675B (en) New methylquinazolinone derivatives
IL283990A (en) Modified oxopyridine derivatives
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
IL289197A (en) History of 2-hydroxycycloalkane-1-carbamoyl
SI3796975T1 (sl) Derivati sulfonilaminobenzamida
CA184991S (en) Uroflowmeter
IL279938A (en) History of spirochroman
CA184994S (en) Uroflowmeter
IL290815A (en) History of alpha-d-galactopyranoside
HUE062256T2 (hu) Dihidrokromén-származékok
SG11202006837XA (en) Dihydroindolizinone derivative
GB201806948D0 (en) Derivatives
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
AU201817248S (en) MC-Roller
AU201817247S (en) MC-Roller
AU201817245S (en) MC-Roller
PT3319956T (pt) Derivados de oxopiridina substituída